1998
DOI: 10.1016/s0002-9149(98)00523-2
|View full text |Cite
|
Sign up to set email alerts
|

Effects of hormone replacement therapy on QT interval

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
36
1
1

Year Published

2002
2002
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(39 citation statements)
references
References 17 publications
1
36
1
1
Order By: Relevance
“…Additionally, we found no differences in APD 90 between premenopausal and postmenopausal women ( Figure 1C), suggesting that the role of gonadal backgrounds is limited, as reported previously. [32][33][34] From the present study, however, we cannot draw firm conclusions regarding age and menopausal effects on APD differences due to the small num- ber of hearts, particularly those of subjects in their teens and twenties. The cardiac AP results from a complex interplay of several time-and voltage-dependent ion currents.…”
Section: Discussioncontrasting
confidence: 65%
“…Additionally, we found no differences in APD 90 between premenopausal and postmenopausal women ( Figure 1C), suggesting that the role of gonadal backgrounds is limited, as reported previously. [32][33][34] From the present study, however, we cannot draw firm conclusions regarding age and menopausal effects on APD differences due to the small num- ber of hearts, particularly those of subjects in their teens and twenties. The cardiac AP results from a complex interplay of several time-and voltage-dependent ion currents.…”
Section: Discussioncontrasting
confidence: 65%
“…2). Although conflicting results exist regarding the effects of endogenous estrogen on the cardiac repolarization process, several clinical studies have reported that exogenous estrogen therapy but not progesterone/estrogen therapy lengthens the QT intervals (Kadish et al, 2004;Carnethon et al, 2003;Larsen et al, 1998). However, the transcriptional targets of estrogen have not been clarified, and no studies have examined the delivery route of exogenous estrogens.…”
Section: Discussionmentioning
confidence: 99%
“…When these studies are compared, the question is whether estrogen predisposes to ventricular rhythm disorders via a torsades de pointes mechanism due to the longer QT interval in women, particularly in those treated with antiarrhythmic drugs, prolonging the QT interval or protects against ventricular arrhythmia by decreasing QTd. Larsen, et al 14) have reported that no significant effect of HRT (estrogen or estrogen plus progesterone) was seen on the QT interval or QTc interval, and the estrogen effect in the dosages and forms given clinically should not increase a woman's risk for torsades de pointes. On the other hand, in a study conducted by Haseroth, et al 17) women receiving HRT for 3 months were separated into two groups-those given only estrogen and others given estrogen plus progesterone-and they were compared with the control group.…”
Section: Discussionmentioning
confidence: 99%
“…13) Therefore, it can be considered that hormone replacement therapy (HRT) leads to early afterdepolarizations and consequently leads to ventricular tachycardia by prolonging the QT interval. 14) In the studies conducted thus for, the effects of short-term HRT on the QTd and corrected QT dispersion (QTcd) on the ECG have been investigated. However, data regarding the effects of long term HRT on QT parameters during resting and exercise ECG are insufficient.…”
mentioning
confidence: 99%